Noscapine
Noscapine is a non-opioid cough suppressant used to relieve dry, irritating coughs that do not involve excessive mucus production. It acts centrally on the cough reflex to reduce the frequency of coughing without producing the typical analgesic or respiratory-depressant effects associated with opioid cough medicines at usual therapeutic doses. Noscapine is commonly available as oral tablets, capsules, or cough syrup, depending on the market. Possible side effects include nausea, dizziness, headache, and gastrointestinal discomfort. It should be used cautiously in individuals with persistent or productive cough, respiratory conditions, or unexplained coughing, as suppressing the cough may delay diagnosis or interfere with mucus clearance. Use should follow medical advice, particularly for children, during pregnancy, or when taking other medicines.
Noscapine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Noscapine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Noscapine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Noscapine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
